Clinical Trial: Study of AHB-171 in Chronic Hepatitis B Participants

U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07630727) titled 'Study of AHB-171 in Chronic Hepatitis B Participants' on June 02.

Brief Summary: The study adopts an open-label, multiple-dose design and aims to evaluate the efficacy and safety of AHB-171 Injection after multiple doses in treatment-naive (HBeAg-negative/positive) and nucleos(t)ide analogue (NA)-treated (HBeAg-negative) participants with chronic hepatitis B (CHB)

Study Start Date: July 15

Study Type: INTERVENTIONAL

Condition: Hepatitis B, Chronic (CHB)

Intervention: DRUG: AHB-171 Injection

Subcutaneous injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Ausper Biopharma Co., Ltd.

Disclaimer: Curated by HT Syndication...